Gene · 7301
Papers2,825
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
541 to 560 of 2,825
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Dysregulation of Protein S in COVID-19. | Best Pract Res Clin Haematol | 2022 | 36494145 | PubTator, text mining | PubMed |
| The mechanisms underlying the immune control of Zika virus infection at the maternal-fetal interface. | Front Immunol | 2022 | 36483552 | PubTator, text mining | PubMed |
| Health care providers' perceptions of using misoprostol in the treatment of incomplete abortion in Malawi. | BMC Health Serv Res | 2022 | 36461125 | PubTator, text mining | PubMed |
| A Necroptosis-Related Gene Signature to Predict the Prognosis of Skin Cutaneous Melanoma. | Dis Markers | 2022 | 36438905 | PubTator, text mining | PubMed |
| ACE2-Independent Alternative Receptors for SARS-CoV-2. | Viruses | 2022 | 36423144 | PubTator, text mining | PubMed |
| Tumor Molecular and Microenvironment Characteristics in EBV-Associated Malignancies as Potential Therapeutic Targets: Focus on Gastric Cancer. | Curr Issues Mol Biol | 2022 | 36421674 | PubTator, text mining | PubMed |
| Cabozantinib sensitizes microsatellite stable colorectal cancer to immune checkpoint blockade by immune modulation in human immune system mouse models. | Front Oncol | 2022 | 36419897 | PubTator, text mining | PubMed |
| Investigation of key signaling pathways and appropriate diagnostic biomarkers selection between non-invasive to invasive stages in pancreatic cancer: a computational observation. | J Med Life | 2022 | 36415513 | PubTator, text mining | PubMed |
| The 8p11 myeloproliferative syndrome: Genotypic and phenotypic classification and targeted therapy. | Front Oncol | 2022 | 36408177 | PubTator, text mining | PubMed |
| Construction of a ferroptosis-related eight gene signature for predicting the prognosis and immune infiltration of thyroid cancer. | Front Endocrinol (Lausanne) | 2022 | 36407322 | PubTator, text mining | PubMed |
| An Overview of Systemic Lupus Erythematosus (SLE) Pathogenesis, Classification, and Management. | Cureus | 2022 | 36407159 | PubTator, text mining | PubMed |
| GPI-anchored ligand-BioID2-tagging system identifies Galectin-1 mediating Zika virus entry. | iScience | 2022 | 36404916 | PubTator, text mining | PubMed |
| Digital transformation of business model innovation. | Front Psychol | 2022 | 36389577 | PubTator, text mining | PubMed |
| An extracellular receptor tyrosine kinase motif orchestrating intracellular STAT activation. | Nat Commun | 2022 | 36376313 | PubTator, text mining | PubMed |
| Metformin Improves Ovarian Cancer Sensitivity to Paclitaxel and Platinum-Based Drugs: A Review of In Vitro Findings. | Int J Mol Sci | 2022 | 36361682 | PubTator, text mining | PubMed |
| Drug Resistance in Cancers: A Free Pass for Bullying. | Cells | 2022 | 36359776 | PubTator, text mining | PubMed |
| Safety of Anti-Angiogenic Drugs in Pediatric Patients with Solid Tumors: A Systematic Review and Meta-Analysis. | Cancers (Basel) | 2022 | 36358734 | PubTator, text mining | PubMed |
| Role of protein phosphorylation in cell signaling, disease, and the intervention therapy. | MedComm (2020) | 2022 | 36349142 | PubTator, text mining | PubMed |
| Preclinical characterization and phase I clinical trial of CT053PTSA targets MET, AXL, and VEGFR2 in patients with advanced solid tumors. | Front Immunol | 2022 | 36341335 | PubTator, text mining | PubMed |
| Construction of the prognostic signature of alternative splicing revealed the prognostic predictor and immune microenvironment in head and neck squamous cell carcinoma. | Front Genet | 2022 | 36338975 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7301/papers?page=28